Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 6, 2010, Pages 1136-1143

  Kathirvel, Elango ^a,b   Chen, Philip ^a,b   Morgan, Kengathevy ^a,b   French, Samuel W ^c   Morgan, Timothy R ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Anti oxidant enzyme; Cytochrome P4502E1 (CYP2E1); Inducible nitric oxide synthase (iNOS); Non alcoholic fatty liver disease (NAFLD); Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBONYL DERIVATIVE; CATALASE; CYTOCHROME P450 2E1; EOSIN; GLUTATHIONE PEROXIDASE; HEMATOXYLIN; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NF E2; TRIACYLGLYCEROL; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; HISTOPATHOLOGY; INSULIN RESISTANCE; LIVER INJURY; MALE; MOUSE; NITROSYLATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; LIVER CELL; LIVER LEVEL; NITROSATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; ENZYMOLOGY; FATTY LIVER; GENETICS; IMMUNOPRECIPITATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATALASE; CYTOCHROME P-450 CYP2E1; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY LIVER; HEME OXYGENASE-1; IMMUNOPRECIPITATION; MALE; MICE; MICE, INBRED BALB C; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 77953017264     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06196.x     Document Type: Article

References (58)

1. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin. Liver Dis. 2001 21 : 17 26.
2. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin. Sci. (Lond) 2008 115 : 141 150.
3. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J. Gastroenterol. Hepatol. 2007 22 : 778 787. (Pubitemid 46915352)
4. Lieber CS. CYP2E1: from ASH to NASH. Hepatol. Res. 2004 28 : 1 11.
5. Laethem RM, Balazy M, Falck JR, Laethem CL, Koop DR. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J. Biol. Chem. 1993 268 : 12912 12918.
6. Kessova I, Cederbaum AI. CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr. Mol. Med. 2003 3 : 509 518.
7. Raucy JL, Lasker J, Ozaki K, Zoleta V. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol. Sci. 2004 79 : 233 241.
8. Koop DR. Alcohol metabolism's damaging effects on the cell: a focus on reactive oxygen generation by the enzyme cytochrome P450 2E1. Alcohol Res. Health 2006 29 : 274 280.
9. Song BJ. Ethanol inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update. Alcohol. Clin. Exp. Res. 1996 20 : 138A 46A.
10. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998 27 : 128 133.
11. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987 235 : 1043 1046.
12. Saha RN, Pahan K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem. Int. 2006 49 : 154 163. (Pubitemid 43867073)
13. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 1993 18 : 195 199.
14. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007 87 : 315 424.
15. Alvarez B, Demicheli V, Duran R et al. Inactivation of human Cu,Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic. Biol. Med. 2004 37 : 813 822.
16. Demicheli V, Quijano C, Alvarez B, Radi R. Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide. Free Radic. Biol. Med. 2007 42 : 1359 1368.
17. Brown GC. Reversible binding and inhibition of catalase by nitric oxide. Eur. J. Biochem 1995 232 : 188 191.
18. Dobashi K, Pahan K, Chahal A, Singh I. Modulation of endogenous antioxidant enzymes by nitric oxide in rat C6 glial cells. J. Neurochem. 1997 68 : 1896 1903.
19. Asahi M, Fujii J, Suzuki K et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J. Biol. Chem. 1995 270 : 21035 21039.
20. Seo HG, Takata I, Nakamura M et al. Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats. Arch. Biochem. Biophys. 1995 324 : 41 7.
21. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 1999 274 : 26071 26078.
22. Zhu H, Itoh K, Yamamoto M, Zweier JL, Li Y. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett. 2005 579 : 3029 3036.
23. Morgan K, French SW, Morgan TR. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 2002 36 : 122 134.
24. Morgan K, Uyuni A, Nandgiri G et al. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 2008 20 : 843 854.
25. Kathirvel E, Morgan K, French SW, Morgan TR. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 2009 21 : 973 983.
26. Yet SF, Melo LG, Layne MD, Perrella MA. Heme oxygenase 1 in regulation of inflammation and oxidative damage. Methods Enzymol. 2002 353 : 163 176.
27. Aebi H. Catalase in vitro. Methods Enzymol. 1984 105 : 121 126.
28. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol. 1994 233 : 229 240.
29. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 1996 271 : C1424 37.
30. Gong P, Cederbaum AI. Transcription factor Nrf2 protects HepG2 cells against CYP2E1 plus arachidonic acid-dependent toxicity. J. Biol. Chem. 2006 281 : 14573 14579.
31. Cederbaum AI. Cytochrome P450 2E1-dependent oxidant stress and upregulation of anti-oxidant defense in liver cells. J. Gastroenterol. Hepatol. 2006 21 (Suppl. 3 S22 5.
32. Gong P, Cederbaum AI. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 2006 43 : 144 153.
33. Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl Acad. Sci. USA 1999 96 : 12731 12736.
34. Shimizu N, Kobayashi K, Hayashi K. The reaction of superoxide radical with catalase. Mechanism of the inhibition of catalase by superoxide radical. J. Biol. Chem. 1984 259 : 4414 4418.
35. Kono Y, Fridovich I. Superoxide radical inhibits catalase. J. Biol. Chem. 1982 257 : 5751 5754.
36. Toussaint O, Houbion A, Remacle J. Relationship between the critical level of oxidative stresses and the glutathione peroxidase activity. Toxicology 1993 81 : 89 101.
37. Zou Y, Li J, Lu C et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life. Sci. 2006 79 : 1100 1107.
38. Saricam T, Kircali B, Koken T. Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. Turk. J. Gastroenterol. 2005 16 : 65 70.
39. Videla LA, Rodrigo R, Orellana M et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond.) 2004 106 : 261 268.
40. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann. Clin. Lab. Sci. 2004 34 : 57 62.
41. Bhardwaj P, Madan K, Thareja S, Joshi YK, Saraya A. Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease. Hepatol. Int. 2008 2 : 202 208.
42. Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 2003 38 : 244 251.
43. Perlemuter G, Davit-Spraul A, Cosson C et al. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int. 2005 25 : 946 953.
44. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003 17 : 1195 1214. (Pubitemid 36775767)
45. Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 2002 32 : 1102 1115.
46. Martinet W, de Meyer GR, Herman AG, Kockx MM. Reactive oxygen species induce RNA damage in human atherosclerosis. Eur. J. Clin. Invest. 2004 34 : 323 327.
47. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 2006 86 : 583 650.
48. Lickteig AJ, Fisher CD, Augustine LM, Cherrington NJ. Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis. J. Biochem. Mol. Toxicol. 2007 21 : 216 220.
49. Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J. Hepatol. 2005 42 : 585 591.
50. Gong P, Cederbaum AI, Nieto N. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway. J. Biol. Chem. 2003 278 : 29693 29700.
51. Gong P, Cederbaum AI, Nieto N. Heme oxygenase-1 protects HepG2 cells against cytochrome P450 2E1-dependent toxicity. Free Radic. Biol. Med. 2004 36 : 307 318.
52. Farombi EO, Surh YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J. Biochem. Mol. Biol. 2006 39 : 479 491.
53. Beltran B, Orsi A, Clementi E, Moncada S. Oxidative stress and S-nitrosylation of proteins in cells. Br. J. Pharmacol. 2000 129 : 953 960.
54. Titov VY, Petrenko YM, Vanin AF. Mechanism of inhibition of catalase by nitro and nitroso compounds. Biochemistry 2008 73 : 92 6.
55. 2-induced oxidative stress on antioxidant enzyme activities. Free Radic. Res. 2009 43 : 340 347.
56. Walshe J, Serewko-Auret MM, Teakle N et al. Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res. 2007 67 : 4751 4758.
57. Viappiani S, Schulz R. Detection of specific nitrotyrosine-modified proteins as a marker of oxidative stress in cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2006 290 : H2167 8.
58. Esposito E, Iacono A, Bianco G et al. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J. Nutr. 2009 139 : 905 911.